ConcensusCriteria of drug-induced liver disorders: Report of an International Consensus Meeting☆
References (12)
Consensus meetings on causality assessment of drug-induced liver injury
J Hepatol
(1988)- et al.
Réunions de consensus sur les définitions en pharmacovigilance
Therapie
(1987) - et al.
Critères d'imputation d'une hépatite aiguë à un médicament. Résultats de réunions de consensus
Gastroenterol Clin Biol
(1987) Diagnosis of drug-induced liver injury (results of consensus meetings)
- et al.
Critères d'imputation d'une cytopénie granuleuse ou plaquettaire à un médicament. Résultats de réunions de consensus
Nouv Rev Fr Hematol
(1987) - et al.
Anémies hémolytiques d'origine médicamenteuse. Résultats de réunions de consensus
Therapie
(1988)
There are more references available in the full text version of this article.
Cited by (1069)
Rosiglitazone induces hepatocyte injury by increasing DCA accumulation through OATP1A4 inhibiting in mice
2023, Arabian Journal of ChemistryMachine-learning-based adverse drug event prediction from observational health data: A review
2023, Drug Discovery TodayA narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer
2023, International ImmunopharmacologyNovel insights into bile acid detoxification via CYP, UGT and SULT enzymes
2023, Toxicology in Vitro
- ☆
This report, prepared by Dr. C. Bénichou of the Division of Pharmacovigilance of Roussel Uclaf, Paris, is the outcome of the work of an international group of experts (listed in Annex 1), which met for 2 days in Paris in June 1989 under the chairmanship of Prof. J.P. Benhamou. The meeting, held under the auspices of the Council for International Organizations of Medical Sciences (CIOMS), was organized by Dr. Bénichou and Dr. G. Danan, also of Roussel Uclaf.
Copyright © 1990 Published by Elsevier Ireland Ltd. All rights reserved.